Distribution of Pseudomonas-derived cephalosporinase and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from Korea

Journal of Microbiology and Biotechnology

Volumn 25, Issue 7, 2015, Pages 1154-1162

  Cho, Hye Hyun ^a   Kwon, Gye Cheol ^b   Kim, Semi ^b   Koo, Sun Hoe ^b  

^a Jeonju Kijeon College   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

AmpC lactamase; Metallo lactamase

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORINASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

AGAR DILUTION; AMPC GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; GENE STRUCTURE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; SOUTH KOREA; TERTIARY CARE CENTER; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PSEUDOMONAS INFECTION;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORINASE; GENETIC VARIATION; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA; TERTIARY CARE CENTERS;

EID: 84937413082     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1503.03065     Document Type: Article

References (33)

1. Bae IK, Suh B, Jeong SH, Wang KK, Kim YR, Yong D, et al. 2014. Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity. Diagn. Microbiol. Infect. Dis. 79: 373-377
2. Cho HH, Kwon KC, Sung JY, Koo SH. 2013. Prevalence and genetic analysis of multidrug-resistant Pseudomonas aeruginosa ST235 isolated from a hospital in Korea, 2008-2012. Ann. Clin. Lab. Sci. 43: 414-419
3. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: twentysecond informational supplement. M100-S22. CLSI, Wayne, Pennsylavania
4. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-β- lactamases: a last frontier for β-lactams? Lancet Infect. Dis. 11: 381-393
5. Grover N, Sahni AK, Bhattacharya S. 2013. Therapeutic challenges of ESBLS and AmpC β-lactamase producers in a tertiary care center. Med. J. Armed Forces India 69: 4-10
6. Huang YT, Chang SC, Lauderdale TL, Yang AJ, Wang JT. 2007. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Diagn. Microbiol. Infect. Dis. 59: 211-216
7. Hu LF, Chang X, Ye Y, Wang ZX, Shao YB, Shi W, et al. 2011. Stenotrophomonas maltophilia resistance to trimethoprim/ sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int. J. Antimicrob. Agents 37: 230-234
8. Jacoby GA. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22: 161-182
9. Lister PD, Wolter DJ, Hanson ND. 2009. Antibacterialresistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22: 582-610
10. Mammeri H, Nordmann P. 2007. Extended-spectrum cephalosporinases in Enterobacteriaceae. Anti-Infect. Agents Med. 6: 71-82
11. Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M. 2014. Determination of extended spectrum β-lactamases, metallo-β-lactamases and AmpC-β-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Burns 40: 1556-1561
12. Pasteran F, Faccone D, Gomez S, De Bunder S, Spinelli F, Rapoport M, et al. 2012. Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J. Antimicrob. Chemother. 67: 1291-1293
13. Pasteran F, Faccone D, Petroni A, Rapoport M, Galas M, Vázquez M, et al. 2005. Novel variant (bla(VIM-11)) of the metallo-{β}-lactamase bla(VIM) family in a GES-1 extendedspectrum-{ β}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob. Agents Chemother. 49: 474-475
14. Pellegrino FL, Teixeira LM, Carvalho Md Mda G, Aranha Nouér S, Pinto De Oliveira M, Mello Sampaio JL, et al. 2002. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J. Clin. Microbiol. 40: 2420-2424
15. Pérez-Pérez FJ, Hanson ND. 2002. Detection of plasmidmediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40: 2153-2162
16. Philippon A, Arlet G, Jacoby GA. 2002. Plasmid-determined AmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46: 1-11
17. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70: 119-123
18. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, et al. 2013. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 57: 410-416
19. Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2: 65
20. Qing Y, Cao KY, Fang ZL, Huang YM, Zhang XF, Tian GB, et al. 2014. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates. J. Med. Microbiol. 63: 386-392
21. Quale J, Bratu S, Gupta J, Landman D. 2006. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 50: 1633-1641
22. Raimondi A, Sisto F, Nikaido H. 2001. Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob. Agents Chemother. 45: 2331-2339
23. Rodríguez-Martínez JM, Poirel L, Nordmann P. 2009. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 1766-1771
24. Rodríguez-Martínez JM, Poirel L, Nordmann P. 2009. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 4783-4788
25. Sanbongi Y, Shimizu A, Suzuki T, Nagaso H, Ida T, Maebashi K, et al. 2009. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiol. Immunol. 53: 361-367
26. Sevillano E, Gallego L, García-Lobo JM. 2009. First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol. Biol. (Paris) 57: 493-495
27. Tian GB, Adams-Haduch JM, Bogdanovich T, Wang HN, Doi Y. 2011. PME-1, an extended-spectrum β-lactamase identified in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55: 2710-2713
28. Upadhyay S, Mishra S, Sen MR, Banerjee T, Bhattacharjee A. 2013. Co-existence of Pseudomonas-derived cephalosporinase among plasmid encoded CMY-2 harbouring isolates of Pseudomonas aeruginosa in north India. Indian J. Med. Microbiol. 31: 257-260
29. Viedma E, Juan C, Acosta J, Zamorano L, Otero JR, Sanz F, et al. 2009. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum β-lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 53: 4930-4933
30. Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, et al. 2010. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals. Int. J. Antimicrob. Agents 35: 486-491
31. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27: 351-353
32. Wright LL, Turton JF, Livermore DM, Hopkins KL, Woodford N. 2015. Dominance of international ‘high-risk clones’ among metallo-β-lactamase-producing Pseudomonas aeruginosa in the UK. J. Antimicrob. Chemother. 70: 103-110
33. Yong D, Shin HB, Kim YK, Cho J, Lee WG, Ha GY, et al. 2014. Increase in the prevalence of carbapenem-resistant Acinetobacter isolates and ampicillin-resistant non-typhoidal Salmonella species in Korea: a KONSAR study conducted in 2011. Infect. Chemother. 46: 84-93.